Literature DB >> 16434897

ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases.

José Vassallo1, Laurence Lamant, Laurence Brugieres, Fanny Gaillard, Elias Campo, Pierre Brousset, Georges Delsol.   

Abstract

Anaplastic large cell lymphoma (ALCL) and Hodgkin lymphoma (HL) are recognized as biologically distinct entities. However, occasionally, these two entities may share some morphologic features responsible for diagnostic difficulties. In the last 10 years, we have collected 380 cases of ALK-positive ALCL of which 10 cases were originally diagnosed as nodular sclerosis classic HL (NSHL) on conventional histopathological examination. After immunostaining, these cases proved to be ALK-positive ALCL mimicking HL (so-called Hodgkin-like ALCL). These cases account for 2.6% of our cases of ALK-positive ALCL (10 of 380 cases). Median age was 11 years (3-92 years) with a female predominance (male/female ratio, 3:7). Characteristically, these lesions showed thick nodular fibrosing bands highly suggestive of NSHL. Neoplastic cells were scarce in 6 cases, whereas in the 4 remaining cases, sheets of tumor cells were also present. A perivascular and a sinusoidal growth pattern was observed in various degrees in all cases. Few binucleated Reed-Sternberg-like cells were present in every case in a background of small lymphocytes. Inflammatory cells (ie, granulocytes, eosinophils, and histiocytes) were rare. Neoplastic cells were positive for CD30 (10 of 10 cases), ALK protein (10 of 10 cases), epithelial membrane antigen (EMA) (9 of 9 cases), CD43 (6 of 9 cases), and perforin (8 of 8 cases), but negative for CD15 (10 of 10 cases), CD20 (10 of 10 cases), Pax5/BSAP (6 of 6 cases), and EBV (8 of 8 cases). In addition, in 7 cases, neoplastic cells were of T-phenotype, whereas the 3 remaining cases were considered to be of null/undetermined phenotype. Although rare, Hodgkin-like ALCL may mimic NSHL, and it is advisable to include EMA in the first line panel and to ask for ALK staining in EMA-positive, CD15-negative lesions with morphologic features suggestive of NSHL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434897     DOI: 10.1097/01.pas.0000179123.66748.c2

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

Review 1.  Diagnosis of Hodgkin lymphoma in the modern era.

Authors:  Hao-Wei Wang; Jayalakshmi P Balakrishna; Stefania Pittaluga; Elaine S Jaffe
Journal:  Br J Haematol       Date:  2018-11-08       Impact factor: 6.998

Review 2.  Epstein Barr virus-associated tumours: an update for the attention of the working pathologist.

Authors:  H-J Delecluse; R Feederle; B O'Sullivan; P Taniere
Journal:  J Clin Pathol       Date:  2007-09-14       Impact factor: 3.411

3.  PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.

Authors:  Andrew L Feldman; Mark E Law; David J Inwards; Ahmet Dogan; Rebecca F McClure; William R Macon
Journal:  Mod Pathol       Date:  2010-01-29       Impact factor: 7.842

4.  Expression of p63 in anaplastic large cell lymphoma but not in classical Hodgkin's lymphoma.

Authors:  Gabriela Gualco; Lawrence M Weiss; Carlos E Bacchi
Journal:  Hum Pathol       Date:  2008-07-11       Impact factor: 3.466

Review 5.  Pitfalls in diagnostic hematopathology -- Part II.

Authors:  Xianfeng F Zhao
Journal:  Int J Clin Exp Pathol       Date:  2009-09-10

6.  Pathobiology of anaplastic large cell lymphoma.

Authors:  Pier Paolo Piccaluga; Anna Gazzola; Claudia Mannu; Claudio Agostinelli; Francesco Bacci; Elena Sabattini; Carlo Sagramoso; Roberto Piva; Fernando Roncolato; Giorgio Inghirami; Stefano A Pileri
Journal:  Adv Hematol       Date:  2011-02-06

7.  Pathobiology of ALK-negative anaplastic large cell lymphoma.

Authors:  Stefano A Pileri; Claudio Agostinelli; Francesco Bacci; Elena Sabattini; Carlo Sagramoso; Brunangelo Falini; Pier Paolo Piccaluga
Journal:  Pediatr Rep       Date:  2011-06-22

Review 8.  Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

Authors:  Suzanne D Turner; Giorgio Inghirami; Roberto N Miranda; Marshall E Kadin
Journal:  Am J Pathol       Date:  2019-10-11       Impact factor: 4.307

Review 9.  The Grey Zones of Classic Hodgkin Lymphoma.

Authors:  Jan Bosch-Schips; Massimo Granai; Leticia Quintanilla-Martinez; Falko Fend
Journal:  Cancers (Basel)       Date:  2022-01-31       Impact factor: 6.639

Review 10.  The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL).

Authors:  Ivonne A Montes-Mojarro; Julia Steinhilber; Irina Bonzheim; Leticia Quintanilla-Martinez; Falko Fend
Journal:  Cancers (Basel)       Date:  2018-04-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.